Madrigal Pharmaceuticals Inc (MDGL)
329.24
+12.15
(+3.83%)
USD |
NASDAQ |
Nov 21, 16:00
329.00
-0.24
(-0.07%)
After-Hours: 20:00
Madrigal Pharmaceuticals Debt to Equity Ratio: 0.1507 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.1507 |
| June 30, 2024 | 0.136 |
| March 31, 2024 | 0.1365 |
| December 31, 2023 | 0.2849 |
| September 30, 2023 | 5.156 |
| June 30, 2023 | 0.9589 |
| March 31, 2023 | 0.5593 |
| December 31, 2022 | 0.2497 |
| September 30, 2022 | 4.591 |
| June 30, 2022 | 0.5826 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.0002 |
| March 31, 2016 | 0.0519 |
| December 31, 2015 | -0.9935 |
| September 30, 2015 | 0.1145 |
| June 30, 2015 | 0.1336 |
| March 31, 2015 | 0.2497 |
| December 31, 2014 | 0.2122 |
| September 30, 2014 | 0.1925 |
| June 30, 2014 | 0.2489 |
| March 31, 2014 | 0.5437 |
| December 31, 2013 | 0.474 |
| September 30, 2013 | 1.609 |
| June 30, 2013 | 0.6695 |
| March 31, 2013 | 0.4174 |
| December 31, 2012 | 0.165 |
| September 30, 2012 | 0.4459 |
| June 30, 2012 | 0.7973 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
5.156
Maximum
Sep 2023
0.6403
Average
0.068
Median
Debt to Equity Ratio Benchmarks
| Corcept Therapeutics Inc | 0.00 |
| ADMA Biologics Inc | 0.437 |
| 89bio Inc | -- |
| Sarepta Therapeutics Inc | 1.005 |
| Matinas BioPharma Holdings Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.073B |
| Total Liabilities (Quarterly) | 296.11M |
| Shareholders Equity (Quarterly) | 777.16M |
| Current Ratio | 5.981 |
| Net Debt Paydown Yield | -0.08% |